• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    5.25 Down 0.10(1.87%) Jan 30, 4:00PM EST
    |After Hours : 5.26 Up 0.01 (0.19%) Jan 30, 5:59PM EST
    Add to Portfolio
    Prev Close:5.35
    Open:5.33
    Bid:N/A
    Ask:6.75 x 200
    1y Target Est:11.17
    Beta:3.79
    Earnings Date:Mar 10 - Mar 16 (Est.)
    Day's Range:5.23 - 5.41
    52wk Range:3.11 - 7.82
    Volume:1,114,617
    Avg Vol (3m):3,139,110
    Market Cap:646.62M
    P/E (ttm):N/A
    EPS (ttm):-0.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OREX

    Comparison

    Symbol% ChgMkt Cap
    OREXDown 1.87%646.62M
    ABTDown 1.10%67.40B
    GSKDown 2.57%105.78B
    RHHBYDown 1.79%189.75B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19.71
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.12
    Quarterly EPS Est (Dec-14) :0.21
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-2.23

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback